Hepatitis C: latest news

Hepatitis C resources

  • Hepatitis C

    Hepatitis C virus (HCV) is chiefly transmitted by blood-to-blood contact. When the blood of a person with hepatitis C enters the bloodstream of another person,...

    From: Factsheets

    Information level Level 2
  • Hepatitis C

    Hepatitis C can cause the same types of symptoms and long-term liver damage as hepatitis B, though the two viruses are not related. Recent estimates find that...

    From: Booklets

    Information level Level 2
  • HIV & hepatitis

    This booklet gives information for people with HIV who also have hepatitis A, hepatitis B or hepatitis C....

    From: Booklets

    Information level Level 2
  • Hepatitis C

    Hepatitis C is a serious infection caused by a virus.It damages the liver, which performs essential functions in the body.Some people have hepatitis C for...

    From: The basics

    Information level Level 1
  • Hepatitis C treatment

    Deciding on the best time to take treatment for hepatitis C is not straightforward.It’s important to get support and advice to help you with this...

    From: The basics

    Information level Level 1
  • How hepatitis C is passed on

    When the blood of a person who has hepatitis C enters the bloodstream of another person, that person could get hepatitis C.Tiny and unseen traces...

    From: The basics

    Information level Level 1
  • How hepatitis C is passed on during sex

    Hepatitis C can be passed on during sex that could lead to contact with small traces of blood.Many gay men with HIV have picked up...

    From: The basics

    Information level Level 1
  • Hepatitis C

    Information on hepatitis C, including transmission, treatment and interactions with HIV and anti-HIV treatment....

    From: HIV treatments directory

    Information level Level 4
  • Hepatitis C virus treatment

    The current preferred treatment regimen for HCV infection is a combination of peginterferon alfa (given by injection) plus ribavirin (given orally). Interferons are human proteins that...

    From: HIV treatments directory

    Information level Level 4

Hepatitis C features

Hepatitis C in your own words

Hepatitis C news from aidsmap

More news

Hepatitis C news selected from other sources

  • Fast Advance in Hepatitis C Care Prompts EMA to Revise Clinical Trial Guideline

    EMA has proposed changes to its guideline on clinical trials of direct acting antiviral hepatitis C drugs. The revisions are intended to ensure the guideline reflects the dramatic changes that have happened in the hepatitis C sector since Gilead introduced its blockbuster Sovaldi (sofosbuvir).

    17 July 2016 | Regulatory Affairs Professionals Society
  • FDA Approves Gilead's Epclusa Combo Pill for All Hepatitis C Genotypes

    On June 28 the U.S. Food and Drug Administration (FDA) approved Gilead Sciences Epclusa, a new once-daily combination pill containing sofosbuvir and velpatasvir, for the treatment of adults with hepatitis C virus (HCV) genotypes 1 through 6 -- the first approved oral pangenotypic regimen. While it is more effective against more types of HCV, Epclusa will cost less than most earlier interferon-free direct-acting antiviral regimens.

    04 July 2016 | HIVandHepatitis.com
  • A boring killer?

    Only 3% of people who have hep C in England have received treatment. What?! How on earth is that acceptable? The problem is that this infection primarily affects injecting drug users and stigma around drug use is preventing public outrage – outrage that could spur on better health treatment.

    14 June 2016 | Addaction
  • Patients who pay £1,000 for life-saving drugs online that would cost NHS £35,000: More and more are doing it - but doctors warn it's a big risk

    Doctors predict that internet drug buyers' clubs are the shape of things to come. Graham Cooke, a consultant in infectious diseases at Imperial College London, says he is supervising NHS patients who have received hep C treatments via fixhepc.com. 'This is a growing trend, as the prices for cancer drugs and other treatments mean they are increasingly unavailable on the NHS,' he adds.

    01 June 2016 | Daily Mail
  • European CHMP Adopts Positive Opinion for Gilead’s Epclusa® (Sofosbuvir/Velpatasvir) for the Treatment of All Genotypes of Chronic Hepatitis C

    Epclusa is Gilead’s Third Sofosbuvir-Based Treatment to Receive a CHMP Positive Opinion for the Treatment of Chronic HCV Infection.

    27 May 2016 | Gilled press relase
  • WHA69: Leave no one behind, World Hepatitis Alliance

    Raquel Peck is the CEO of the World Hepatitis Alliance (WHA), she shares her hope that stronger action on viral hepatitis will be high on the agenda for the 69th World Health Assembly in Geneva (convening this week).

    25 May 2016 | PLoS Blogs (blog)
  • Could hepatitis C treatments help prevent virus transmission?

    In a study looking specifically at HCV infection rates in HIV-positive gay men, the researchers found the proportion of HIV positive gay men with HCV increased slightly from 2004 to 2011, and that current treatment rates were unlikely to reduce HCV transmission over time.

    19 May 2016 | Eurekalert Inf Dis
  • Outside the biomedical box of hepatitis C research

    Interview with Magdalena Harris, Lecturer at the London School of Hygiene and Tropical Medicine, on how she came to work with viral hepatitis, how the field has been changing, and what new research is called for.

    17 May 2016 | BioMed Central blogs
  • Consultation for action plans on HIV and viral hepatitis

    The joint Tuberculosis, HIV/AIDS and Hepatitis Programme of the WHO Regional Office for Europe is developing two action plans to address the HIV and viral hepatitis epidemics in the WHO European Region.

    17 May 2016 | WHO Europe
  • Philip Christopher Baldwin: “We need better access to treatment for gay men living with HIV and Hep C”

    I am saddened by the delay in the provision of Hep C treatment in the UK. Of the 103,700 people living with HIV in the UK, nine per cent are co-infected with Hep C, many of them gay men. It is unfair that we have to cope with Hep C without help. We have a treatment which can cure Hep C, but the treatment is being withheld by the NHS for funding reasons.

    11 May 2016 | Gay Times
More news

Our information levels explained

  • Short and simple introductions to key HIV topics, sometimes illustrated with pictures.
  • Expands on the previous level, but also written in easy-to-understand plain language.
  • More detailed information, likely to include medical and scientific language.
  • Detailed, comprehensive information, using medical and specialised language.
Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap